KRAS and cancer: Of note, although UCP2 is overexpressed in many cancer types [96], its expression is not induced by KRAS mutations, since the expression of the G12V mutant in BxPC3, a PDAC cell line carrying the wild-type form of KRAS, did not alter the expression of UCP2.